Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117477) titled 'Circulating tumor DNA as a prognostic biomarker in head and neck squamous cell carcinoma: a prospective cohort study' on Jan. 25.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Hospital of China Medical University
Condition:
Head and Neck Squamous Cell Carcinoma
Intervention:
Curative-Intent Treatment Cohort:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-26
Target Sample Size: Curative-Intent Treatment Cohort:60;Recurrent/Metastatic Treatment Cohort:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.or...